Sponsor Check › Person
Named as an officer, director or promoter on SEC Form D filings · MA · Dec 16, 2009 → Apr 30, 2026
Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:17 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET
Michael Cima is listed as an executive officer and director on 16 SEC Form D filings by 5 issuers between Dec 2009 and Apr 2026: T2 Biosystems, Inc. (Lexington, MA — other health care — 2010–2013; $400M reported sold to 16 investors), SpringLeaf Therapeutics, Inc. (Boston, MA — pharmaceuticals — 2011; $19M reported sold to 8 investors), Microchips Biotech, Inc. (Lexington, MA — other health care — 2015; $18.6M reported sold to 11 investors), TARIS BIOMEDICAL INC (Lexington, MA — biotechnology — 2009–2013; $18.4M reported sold to 11 investors) and GelMEDIX, Inc. (Cambridge, MA — biotechnology — 2022–2026; $6.44M reported sold to 17 investors).
What this means A repeat sponsor — 5 separate companies raised money with this person listed as executive officer and director, over about 17 years. Across those companies the filings report $462.5M sold in total.
Listed alongside Michael Greeley (9 shared filings), Robert Langer (8 shared filings), Nasim Annabi (6 shared filings), Parinaz Motamedy (6 shared filings), Reza Dana (6 shared filings) and 38 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Michael. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CO, CT, DC, DE, FINRA, FL, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, WA, WI, WV, WY) — 31 court cases matching the name, 29 bankruptcy cases matching the name listed in Key records below.
What this means 60 records came back, including 1 court case still open — open cases can take years and cost money. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 16 public filings for Michael Cima and found 11 differences, 2 worth asking the sponsor about: Amount sold went down between filings; Investor count went down between filings; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.
Community search for Michael Cima has not run yet — it is joining a line of 55,558 names; searches run around the clock at the hosts' allowed rate. Searched so far: 641 names.
Community comments are quoted as written by their authors. Sources searched: Bing (site:reddit.com / site:biggerpockets.com) and Reddit's own search, plus DuckDuckGo/Brave/BiggerPockets search when they are answering.
Five things investors ask first. Items still in human review are counted, not shown.
31 cases: 12 closed (disposition not in docket feed), 15 dismissed, 3 judgment, 1 open
376 Qui Tam (31 U.S.C. § 3729(a))· Cause:
31:3730 Qui Tam False Claims Act
190 Other contract actions
190 Other contract actions
890 Other Statutory Actions· Cause:
28:1452 R&R re motions to remand (non-core)
190 Contract: Other· Cause:
28:1332 Diversity-Injunctive & Declaratory Relief
190 Contract: Other· Cause:
28:1332 Diversity-Other Contract
190 Other contract actions
190 Other contract actions
150 Overpayments & enforcement of judgments
370 Other Fraud· Cause:
18:1030 Violation of Computer Fraud and Abuse Act
422 Bankruptcy appeals rule 28 USC 158
422 Bankruptcy appeals rule 28 USC 158
423 Bankruptcy withdrawal 28 USC 157
380 Other personal property damage
190 Other contract actions
190 Other contract actions
190 Other contract actions
190 Contract: Other· Cause:
28:1332 Diversity-Breach of Contract
190 Other contract actions
130 Miller act
130 Miller act
130 Miller act
330 Federal employers' liability
330 Federal employers' liability
330 Federal employers' liability
190 Other contract actions
Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:17 AM ET.
Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.
State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: 48 regulators (FINRA, NASAA, 37 states) — crawled Oct 24, 2026, 8:48 AM ET
SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Michael Cima..
State securities regulators: Securities regulators searched (64,910 actions): FINRA (38,350 actions, 1995–2026), NASAA (31 actions, 2000–2026; listing starts 1997), AK Division of Banking and Securities (273 actions, 1971–2025), AL Securities Commission (880 actions, 2001–2026), AR Securities Department (1,305 actions, 1998–2026), AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), CO Division of Securities (731 actions, 2001–2026; older years from the Internet Archive (snapshot of 2026-05-02)), CT Department of Banking Securities Division (940 actions, 2006–2026; older years from the Internet Archive (snapshot of 2026-04-22)), DC DISB Securities Bureau (25 actions, 2012–2026), DE DOJ Investor Protection Unit (257 actions, 1987–2026), FL Office of Financial Regulation (49 actions, 2018–2026), GA Secretary of State Securities Division (65 actions, 2015–2026; listing starts 2012), HI DCCA Securities Enforcement Branch (26 actions, 2012–2026), ID Department of Finance Securities Bureau (663 actions, 1994–2026), IL Secretary of State Securities Department (4,122 actions, 2003–2023), KS Insurance Department Securities Division (58 actions), KY Department of Financial Institutions (342 actions, 2005–2026), LA Office of Financial Institutions Securities Division (13 actions, 2010–2025; listing starts 2008), MA Secretary of the Commonwealth Securities Division (125 actions, 2012–2025; live site blocks automated access — loaded from the Internet Archive snapshot of 2026-02-04), MD Attorney General Securities Division (1,054 actions, 2004–2026), ME Office of Securities (539 actions, 2000–2026), MI LARA Corporations, Securities & Commercial Licensing Bureau (201 actions), MO Secretary of State Securities Division (919 actions, 1998–2026), MS Secretary of State Securities Division (209 actions, 1995–2026), MT Commissioner of Securities and Insurance (597 actions, 2000–2026), NC Secretary of State Securities Division (265 actions, 2004–2024), ND Securities Department (711 actions, 1990–2026; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2026-01-06), NH Bureau of Securities Regulation (402 actions, 2002–2026), NM Regulation and Licensing Department Securities Division (90 actions, 2010–2025), NV Secretary of State Securities Division (118 actions, 2018–2026), NY Attorney General Investor Protection Bureau (44 actions, 2012–2026), OH Division of Securities (327 actions, 1993–2006), OK Department of Securities (2,531 actions, 1998–2026), OR Division of Financial Regulation (589 actions, 1988–2026), PA Department of Banking and Securities (1,448 actions, 2008–2024; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2024-08-09), RI DBR Securities Division (98 actions, 2005–2025), SC Attorney General Securities Division (540 actions, 2006–2026), SD Division of Insurance – Securities Regulation (106 actions, 2017–2026), TN Department of Commerce and Insurance Securities Division (405 actions, 1992–2026), TX State Securities Board (936 actions, 1999–2026), UT Division of Securities (772 actions, 2000–2026; older years from the Internet Archive (snapshot of 2010-05-27)), VT DFR Securities Division (137 actions, 2010–2026), WA DFI (2,039 actions, 2001–2026), WI DFI Division of Securities (1,072 actions, 1998–2026), WV Securities Commission (State Auditor) (64 actions), WY Secretary of State Compliance Division (6 actions, 2016–2024) — last crawled Oct 24, 2026, 8:48 AM ET. No machine-readable public listing today for IA, IN, MN, NE, NJ, VA (see docs/state-regulators.md).
29 cases: 2 open, 27 closed (disposition not in docket feed)
Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:17 AM ET.
Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.
State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
Comparisons cover issuers and sponsor groups — see the issuer pages under Deals
11 differences found between the filings for Michael Cima — 2 worth asking about (compared 16 filings on Oct 24, 2026)
United States Bankruptcy Court, D. Massachusetts docket "Arthur R. Driscoll" filed Aug 10, 1995, closed Dec 5, 1995. Arthur Driscoll (listed on the same filings) is listed as Debtor ("Arthur R. Driscoll"). Our match estimate: 70%.
What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.
The Apr 13, 2011 filing says $18,372,751 sold; the Apr 2, 2013 Form D/A says $13,500,000 sold — $4,872,751 less.
What this means Amounts sold normally only go up as a raise continues. A drop can mean investors were refunded, a figure was corrected, or an earlier number was wrong. Ask the sponsor which it was.
The Apr 2, 2013 filing reports 11 investors; the Apr 4, 2013 Form D/A reports 8 investors.
What this means Investor counts normally only grow. A smaller number can mean investors left or were refunded, or a count was corrected. Ask the sponsor what happened.
The Oct 14, 2025 Form D reports $397,000 sold and $40,000 of the proceeds used for payments to officers, directors or promoters (marked as an estimate).
What this means The filing reports how much of the money raised was paid to insiders. Over 10% is high for most deals. Ask what it paid for.
No amendment in the last 12 months on an offering that may still be open — GelMEDIX, Inc. (latest filing Feb 4, 2025) · No amendment in the last 12 months on an offering that may still be open — GelMEDIX, Inc. (latest filing Mar 26, 2024) · No amendment in the last 12 months on an offering that may still be open — GelMEDIX, Inc. (latest filing Aug 10, 2022) · No amendment in the last 12 months on an offering that may still be open — TARIS BIOMEDICAL INC (latest filing Apr 4, 2013) · No amendment in the last 12 months on an offering that may still be open — T2 Biosystems, Inc. (latest filing May 28, 2010)
What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.
The Dec 16, 2009 filing lists Michael Cima as executive officer, director; the Apr 13, 2011 Form D lists director.
What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.
Offering amount changed between filings — GelMEDIX, Inc. · Offering amount changed between filings — GelMEDIX, Inc. · Offering amount changed between filings — GelMEDIX, Inc. · Offering amount changed between filings — TARIS BIOMEDICAL INC · Offering amount changed between filings — TARIS BIOMEDICAL INC · and 1 more
What this means Targets change as deals grow or shrink. Ask whether later money has the same terms.
listed as "Michael Cima" on 15 filings (from Dec 16, 2009), and "Michael J. Cima" on the Jun 24, 2015 filing.
What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.
The people listed on the Apr 29, 2021 filing give Newton, MA; on the Aug 10, 2022 filing they give Cambridge, MA.
What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.
The people listed on the May 28, 2010 filing give Cambridge, MA; on the Aug 10, 2011 filing they give Lexington, MA.
What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.
The people listed on the Dec 16, 2009 filing give Waltham, MA; on the Apr 13, 2011 filing they give Lexington, MA.
What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.
What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.
0 of 11 offerings report sales commissions; 0 report finder's fees; 2 report proceeds to related persons totalling $223,333. (includes amounts the issuer reported as estimates)
| Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it | Source |
|---|---|---|---|---|---|
| Apr 30, 2026 D/A GelMEDIX, Inc. File 021-560746 | $0 | $0 | $40,000 (est.) | None listed on this filing | EDGAR ↗ |
| Feb 4, 2025 D GelMEDIX, Inc. File 021-537321 | $0 | $0 | $0 The proceeds are available to fund general working capital requirements; as of the date of this filing no detailed operating budget has been adopted; and no proceeds have been or are proposed to be used for payments of compensation. | None listed on this filing | EDGAR ↗ |
| Mar 26, 2024 D GelMEDIX, Inc. File 021-508626 | $0 | $0 | $183,333 | None listed on this filing | EDGAR ↗ |
| Aug 10, 2022 D/A GelMEDIX, Inc. File 021-369335 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jun 24, 2015 D Microchips Biotech, Inc. File 021-242364 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Apr 4, 2013 D/A TARIS BIOMEDICAL INC File 021-158321 | $0 | $0 | $0 This amendment is being filed to withdraw the Form D amendment filed on April 2, 2013 which was inadvertently submitted. | None listed on this filing | EDGAR ↗ |
| Mar 28, 2013 D T2 Biosystems, Inc. File 021-194118 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Aug 10, 2011 D T2 Biosystems, Inc. File 021-164197 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jul 8, 2011 D/A SpringLeaf Therapeutics, Inc. File 021-159732 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| May 28, 2010 D T2 Biosystems, Inc. File 021-142704 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Dec 16, 2009 D TARIS BIOMEDICAL INC File 021-122485 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.
Counted across every filing this person is listed on (latest filing per offering, per issuer).
Every issuer that named Michael Cima on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.
Raised $6.44M from 17 investors (100% of the $2.5M target) as of the latest filing. Michael is listed as director on 6 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $18.6M from 11 investors (100% of the $18.6M target) as of the latest filing. Michael is listed as director.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $18.4M from 11 investors (98% of the $18.7M target) as of the latest filing. Michael is listed as director, executive officer on 4 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.
Raised $400M from 16 investors (100% of the $400M target) as of the latest filing. Michael is listed as director on 3 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.
Raised $19M from 8 investors (100% of the $19M target) as of the latest filing. Michael is listed as director on 2 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.
Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.
Michael Greeley is on 18 issuers in total — a repeat sponsor. Their page lists every one.
Robert Langer is on 48 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Michael Cima. Their page shows their other deals.
Listed on the same filings as Michael Cima. Their page shows their other deals.
Kevin Bitterman is on 24 issuers in total — a repeat sponsor. Their page lists every one.
Alan Crane is on 12 issuers in total — a repeat sponsor. Their page lists every one.
John McDonough is on 6 issuers in total — a repeat sponsor. Their page lists every one.
Kurt Graves is on 7 issuers in total — a repeat sponsor. Their page lists every one.
Jeffrey McCarthy is on 9 issuers in total — a repeat sponsor. Their page lists every one.
Brian Gallagher is on 7 issuers in total — a repeat sponsor. Their page lists every one.
HARRY WILCOX is on 7 issuers in total — a repeat sponsor. Their page lists every one.
Garen Bohlin is on 7 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Michael Cima. Their page shows their other deals.
David Neafus is on 11 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Michael Cima. Their page shows their other deals.
Robert Crane is on 7 issuers in total — a repeat sponsor. Their page lists every one.
Terrance McGuire is on 21 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Michael Cima. Their page shows their other deals.
Cary Pfeffer is on 9 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Michael Cima. Their page shows their other deals.
A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.
Individuals are not matched to business registrations — registries list companies, and a name alone is not enough to tie a person to one. Officers and managers appear by name inside each matched company's record on the issuer pages. Registries searched: AL (Alabama Secretary of State — Business Entity Records (arc-sos.state.al.us), searched by issuer name, data as of Oct 24, 2026); CO (Colorado Secretary of State — Business Entities in Colorado (data.colorado.gov), data as of Oct 23, 2026); CT (Connecticut Secretary of the State — Business Registry (data.ct.gov), data as of Oct 24, 2026); FL (Florida Department of State, Division of Corporations — quarterly corporate data file (Sunbiz), data as of Oct 7, 2026); KY (Kentucky Secretary of State — Business Entity Search (sosbes.sos.ky.gov), searched by issuer name, data as of Oct 24, 2026); NY (New York Department of State — Corporations and Other Entities (data.ny.gov: All Filings + Active Corporations), data as of Oct 20, 2026); OR (Oregon Secretary of State — Active Businesses, All (data.oregon.gov), data as of Oct 20, 2026); PA (Pennsylvania Department of State — Registered Businesses, Current (data.pa.gov), data as of Oct 6, 2026); TX (Texas Comptroller — Active Franchise Taxpayers incl. Secretary of State file data (data.texas.gov), data as of Oct 24, 2026). Registries of other states have not been searched: many publish no bulk file and require a CAPTCHA or bot challenge on their search page, which we do not bypass (Delaware, for example, offers no public bulk file).
None of the 5 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.
Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.
Property records are matched to companies only, never to individuals, so none are matched to Michael Cima by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 5 issuers this person is listed on — nothing matched.
Websites and social links of the issuers Michael Cima is listed on: none on file. No website or social profile named in Microchips Biotech, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #301,026 of 374,652 in line (1,386 issuers searched so far). One-tap searches: Look further ↓
One-tap searches on sites we do not index ourselves, with the name pre-filled (Lexington, MA). Each opens in a new tab; what you find there is not verified by PartnerFacts.
No corrections have been requested for this page.
Free. Logged with status: received → under review → fixed / confirmed with source.
If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.
Members get an email when Michael Cima appears on a new Form D, or when a court case or SEC action is matched to them. See plans →